Cargando…
Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder
In this study, we obtained a lipidomic profile of plasma samples from drug-naïve patients with schizophrenia (SZ) and bipolar disorder (BD) in comparison to healthy controls. The sample cohort consisted of 30 BD and 30 SZ patients and 30 control individuals. An untargeted lipidomics strategy using l...
Autores principales: | Costa, Alana C., Riça, Larissa B., van de Bilt, Martinus, Zandonadi, Flávia S., Gattaz, Wagner F., Talib, Leda L., Sussulini, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222421/ https://www.ncbi.nlm.nih.gov/pubmed/37233641 http://dx.doi.org/10.3390/metabo13050600 |
Ejemplares similares
-
Plasma Metabolite Profiles in First Episode Psychosis: Exploring Symptoms Heterogeneity/Severity in Schizophrenia and Bipolar Disorder Cohorts
por: Joaquim, Helena P. G., et al.
Publicado: (2020) -
S193. EFFICACY AND SAFETY OF TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE FOLLOW-UP PHASE
por: Valiengo, Leandro, et al.
Publicado: (2020) -
Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis
por: Costa, Alana, et al.
Publicado: (2022) -
T51. TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH TRANSCRANIAL CURRENT STIMULATION (TDCS): RESULTS OF RANDOMIZED, DOUBLE-BLINDED, SHAM-CONTROLLED TRIAL
por: Valiengo, Leandro, et al.
Publicado: (2018) -
Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry
por: Nucifora, L G, et al.
Publicado: (2017)